Jane is managing partner of Militia Hill Ventures, a business focused on building, growing and investing in high-quality life sciences companies. She also serves as a director on multiple life sciences companies and as executive chair of Eliksa Therapeutics, a rare disease company. She is the former CEO of Immunome Inc., a cancer immunotherapy company, and co-founder and former CEO of NuPathe Inc., a neurology focused biopharmaceutical company that was sold to Teva.